Last Updated:
Sun Pharma Q4 Results: Its consolidated net profit falls 19% YoY to Rs 2,153.93 crore, against a profit of Rs 2,658.74 crore a year ago.
Sun Pharma Dividend 2025.
Sun Pharmaceutical Industries Ltd has recommended a final dividend of Rs 5.50 per equity share of face value Rs 1 each for FY 2024-25. The dividend is subject to shareholder approval at the upcoming annual general meeting (AGM).
The company has fixed Monday, July 7, 2025, as the record date to determine eligible shareholders for the final dividend. If approved at the AGM, the dividend will be paid on or before Friday, August 8, 2025.
Sun Pharma reported a 19 per cent YoY decline in its consolidated net profit to Rs 2,153.93 crore for the March 2025 quarter, against a profit of Rs 2,658.74 crore a year ago. Its total revenue from operations, however, increased 8 per cent YoY to Rs 12,958.84 crore from Rs 11,982.90 crore in the year-ago period.
Shares of Sun Pharma on Thursday fell by 0.76 per cent to close at Rs 1,718.70 apiece on the BSE.
- First Published: